Anne W. Alexandrov

Apr 6, 2024 | uscjournal.com | Harriette Van Spall |Michael Gibson |Joost Daemen |Anne W. Alexandrov

ACC 2024 — Late-breaker host, Dr Harriette Van Spall and Principal Investigator, Dr C Michael Gibson discuss the AEGIS-II trial (CSL Behring) (NCT03473223). This phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study investigated the efficacy and safety of an apolipoprotein A-I (apoA-I), CSL112 in patients with acute coronary syndrome (ACS). Investigators enrolled 18200 participants.

Feb 19, 2024 | radcliffecardiology.com | Anne W. Alexandrov |James Burton |David C. Wheeler |Carol Pollock

AHA ISC 2024 — Dr Anne Alexandrov (University of Tennessee Health Science Center, US) joins us to summarise the key findings from the Zero Degree Head Positioning in Hyperacute Large Artery Ischaemic Stroke (ZODIAC) trial (NCT03728738). ZODIAC is a prospective randomized open blinded endpoint (PROBE) clinical trial investigating head positioning in hyperacute LVO ischemic stroke treatment.

Feb 16, 2024 | neurologylive.com | Anne W. Alexandrov

WATCH TIME: 6 minutes "Our study shows that head-of-bed positioning at 0 degrees, rather than 30 degrees, significantly enhances patients' stability and reduces disability, leading to less days in rehabilitation.” Previous research in patients with large vessel occlusion (LVO) prior to undergoing thrombectomy showed a significant 20% increase in blood flow and improvements in the clinical exam when patient’s head was placed at 0-degrees.1 In a recent study presented at the 2024 International...